HomeCompareNIDB vs PFE

NIDB vs PFE: Dividend Comparison 2026

NIDB yields 3.30% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $28.7K in total portfolio value· pulled ahead in Year 9
10 years
NIDB
NIDB
● Live price
3.30%
Share price
$22.40
Annual div
$0.74
5Y div CAGR
-30.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.9K
Annual income
$8.69
Full NIDB calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — NIDB vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNIDBPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NIDB + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NIDB pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NIDB
Annual income on $10K today (after 15% tax)
$280.80/yr
After 10yr DRIP, annual income (after tax)
$7.39/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,312.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NIDB + PFE for your $10,000?

NIDB: 50%PFE: 50%
100% PFE50/50100% NIDB
Portfolio after 10yr
$35.2K
Annual income
$13,133.71/yr
Blended yield
37.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

NIDB
No analyst data
Altman Z
0.2
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NIDB buys
0
PFE buys
0
No recent congressional trades found for NIDB or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNIDBPFE
Forward yield3.30%6.13%
Annual dividend / share$0.74$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-30.9%13.2%
Portfolio after 10y$20.9K$49.6K
Annual income after 10y$8.69$26,258.71
Total dividends collected$739.00$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NIDB vs PFE ($10,000, DRIP)

YearNIDB PortfolioNIDB Income/yrPFE PortfolioPFE Income/yrGap
1$10,928$228.28$9,153$693.39+$1.8KNIDB
2$11,854$161.10$8,593$849.25+$3.3KNIDB
3$12,797$112.86$8,336$1,066.78+$4.5KNIDB
4$13,771$78.68$8,437$1,384.80+$5.3KNIDB
5$14,790$54.68$9,013$1,875.40+$5.8KNIDB
6$15,863$37.92$10,306$2,680.72+$5.6KNIDB
7$17,000$26.27$12,820$4,101.38+$4.2KNIDB
8$18,208$18.18$17,673$6,826.70+$535.00NIDB
9← crossover$19,495$12.57$27,543$12,591.86$8.0KPFE
10$20,869$8.69$49,560$26,258.71$28.7KPFE

NIDB vs PFE: Complete Analysis 2026

NIDBStock

Northeast Indiana Bancorp, Inc. operates as the bank holding company for First Federal Savings Bank that provides various banking and financial advisory services. The company offers various personal products, including checking accounts, savings accounts, retirement accounts, health savings accounts, and direct deposits, as well as certificates of deposit. Its loan portfolio comprises mortgage loans, such as home purchases, refinances, new construction loans, and home equity/home improvement loans; installment loans consisting of auto loans, personal loans, short term notes, and savings account loans, as well as RV, ATV, and boat loans; and commercial loans, including lines of credit, letters of credit, equipment financing, and construction loans, as well as revolving line of credit, term loans, real estate loans, and small business administration loans. The company also offers debit and credit cards, safe deposit boxes, online banking services, merchant services, and cash management services, as well as treasury management and merchant deposit capture services. In addition, it provides various financial services to individual and corporate clients, including brokerage accounts, retail funds, and wealth management products, as well as insurance products and retirement plans. As of January 28, 2022, the company operated five full-service offices in Huntington; 2 offices in Warsaw; and 2 offices in Fort Wayne, Indiana. Northeast Indiana Bancorp, Inc. was incorporated in 1995 and is headquartered in Huntington, Indiana.

Full NIDB Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this NIDB vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NIDB vs SCHDNIDB vs JEPINIDB vs ONIDB vs KONIDB vs MAINNIDB vs JNJNIDB vs MRKNIDB vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.